ABOUT THE WEBINAR
The AI-SPRINT Personalised Healthcare Use Case exploits the potential offered by the edge-cloud environment to develop innovative and impactful clinical applications for stroke prevention. The use case benefits from incorporating wearable technology into healthcare, such as continuous data acquisition and low patient burden. This novel approach will be tested over the next few years, collecting different kinds of information and combining quantitative and qualitative data per patient while preserving both privacy and security of the people concerned.
The webinar zooms in on the drivers, benefits and societal impacts for personalised healthcare.
MAIN AUDIENCE AND KEY TAKEAWAYS
The webinar targets:
- SMEs and AI application developers interested in solutions that balance accuracy with privacy constraints, including compliance with national and European regulatory requirements, while guaranteeing performance all the way from IoT up to the cloud.
- EU Digital Innovation Hubs interested in adopting new trustworthy technologies in the healthcare sector.
- Healthcare organisations and associations, with a mission to improve patient care for stroke incidence.
WATCH THE RECORDED VIDEO!
|16:00 - 16:15||Setting the scene: stroke incidence in Europe||Arlene Wilkie, Stroke Alliance for Europe - SAFE|
|16:15 - 16:30||AI-SPRINT Personalised Healthcare use case||Davide Cirillo, Barcelona Supercomputing Center|
|16:30 - 16:35||A real life experience from a stroke incidence||Julio Agredano, Fundación Freno al ICTUS|
|16:35 - 17:05||Panel discussion|
|17:05 - 17:10||Interactive poll session with participants|
|17:10 - 17:20||Wrap-up and conclusion|
ABOUT THE SPEAKERS
- Arlene Wilkie, General Director at Stroke Alliance for Europe - SAFE
Arlene Wilkie is currently the General Directore at SAFE, the Stroke Alliance for Europe. She has an extensive experience and expertise in the area, derived from a variety of organisations and roles over the last twenty years in the healthcare sector, primarily in patient focused organisations she has been involved in. These include Director of Research and Policy at Breast Cancer Campaign, Chief Executive of the Neurological Alliance (a membership organisation of 70 neurological organisations in England), Chief Executive of The Migraine Trust, and Interim Director of Services and Influencing at the Brain Tumour Charity UK.
- Davide Cirillo, postdoctoral researcher at Barcelona Supercomputing Center
Davide Cirillo, Ph.D., is a postdoctoral researcher at Barcelona Supercomputing Center (BSC) Computational Biology group, Life Sciences Department. Davide Cirillo received the MSc degree in Pharmaceutical Biotechnology from University of Roma ‘La Sapienza’, Italy, and the PhD degree in Biomedicine from Universitat Pompeu Fabra (UPF) and Center for Genomic Regulation (CRG) of Barcelona, Spain. His research is devoted to the development and application of computational methods in Precision Medicine with a special emphasis on Machine Learning and Artificial Intelligence.
- Oscar Lozano, Co-founder and CEO at Rithmi
Oscar Lozano holds a degree in Business Administration. Former founder and CEO of strokestrike.com, platform to prevent stroke awarded with the 1mission1Million Award. He is experienced as co-founder of several companies in the field of electronics and promotional gifts. Since 2016, he has been dedicated full time to the strategic and operational management of Rithmi, where he currently leads a team of 7 people.
- Julio Agredano, Founder and President at Fundación Freno al ICTUS
Julio Agredano is the founder and president of Fundación Freno al ICTUS, which aims to communicate and find solutions to reduce the stroke incidence in our society.
- Enara Herran Martinez, International R&D Project Collaborator at Fundación Freno al ICTUS
Enara Herran Martinez holds a PhD in pharmacy in the field of Neurodegenerative Diseases and she is currently an International R&D project Collaborator at Freno al Ictus Foundation. She is specialised in developing new health care models to allow significant enhancement on process efficiency, in order to facilitate access to preventive, predictive and personalised medicine. Her field of expertise focuses on maximising the value created in patients with specific clinical conditions by taking advantage of new digital technologies with the ultimate goal of improving patient health.
- María Alonso de Leciñana, Stroke neurologist at “La Paz Hospital”
María Alonso de Leciñana is Associate Professor of Clinical Neurology at the Universidad Autónoma de Madrid, a Stroke neurologist at the Department of Neurology & Stroke Center, University Hospital La Paz, where coordinates the Unit for Innovation and Digitization of the Department. She is a senior researcher at the Institute for Health Research IdiPAZ, Madrid, Spain.
Her clinical and research activities are focused on acute stroke treatment and on brain repair and recovery after stroke.
She has been chair of the Stroke Group of the Spanish Society of Neurology (SEN) and President of the Iberoamerican Stroke Organization. She is fellow of the ESO and has been member of the Stroke Panel of the EAN.
She has 174 publications attracting 2,240 citations with an H index of 22.